MEDPACE HOLDINGS INC (MEDP) Forecast, Price Target & Analyst Ratings

NASDAQ:MEDP • US58506Q1094

Current stock price

410.54 USD
+17.12 (+4.35%)
At close:
410.2 USD
-0.34 (-0.08%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MEDPACE HOLDINGS INC (MEDP).

Forecast Snapshot

Consensus Price Target

Price Target
$503.37
+ 22.61% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Jul 20, 2026
Period
Q2 / 2026
EPS Estimate
$4.16
Revenue Estimate
716M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
72.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$503.37
Upside
+ 22.61%
From current price of $410.54 to mean target of $503.37, Based on 20 analyst forecasts
Low
$341.82
Median
$510.00
High
$630.00

Price Target Revisions

1 Month
1.19%
3 Months
-9.14%

Price Target Summary

20 Wall Street analysts provided a forecast for the next 12 months for MEDP. The average price target is 503.37 USD. This implies a price increase of 22.61% is expected in the next year compared to the current price of 410.54.
The average price target has been revised downward by 9.14% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

MEDP Current Analyst RatingMEDP Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8

Analyst Ratings History

MEDP Historical Analyst RatingsMEDP Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
72.00%
MEDP was analyzed by 20 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about MEDP.
In the previous month the buy percentage consensus was at a similar level.
MEDP was analyzed by 20 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-04-24BMO CapitalMaintains Market Perform -> Market Perform
2026-04-24RBC CapitalMaintains Outperform -> Outperform
2026-04-24BarclaysMaintains Equal-Weight -> Equal-Weight
2026-04-24BairdMaintains Outperform -> Outperform
2026-03-06BarclaysUpgrade Underweight -> Equal-Weight
2026-03-03RBC CapitalInitiate Outperform
2026-02-18TD CowenUpgrade Sell -> Hold
2026-02-13JefferiesUpgrade Hold -> Buy
2026-02-11Leerink PartnersMaintains Market Perform -> Market Perform
2026-02-11BarclaysMaintains Underweight -> Underweight
2026-02-11Truist SecuritiesMaintains Hold -> Hold
2025-12-15BarclaysMaintains Underweight -> Underweight
2025-11-13BMO CapitalInitiate Market Perform
2025-10-24TD CowenMaintains Sell -> Sell
2025-10-24MizuhoMaintains Outperform -> Outperform
2025-10-24BarclaysMaintains Underweight -> Underweight
2025-10-17MizuhoMaintains Outperform -> Outperform
2025-10-02BarclaysDowngrade Equal-Weight -> Underweight
2025-09-09JefferiesMaintains Hold -> Hold
2025-09-03Rothschild & CoDowngrade Buy -> Neutral
2025-07-29UBSDowngrade Neutral -> Sell
2025-07-25MizuhoMaintains Outperform -> Outperform
2025-07-23TD CowenDowngrade Hold -> Sell
2025-07-23Deutsche BankMaintains Hold -> Hold
2025-07-23BarclaysMaintains Equal-Weight -> Equal-Weight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Jul 20, 2026
Period
Q2 / 2026
EPS Estimate
$4.16
Revenue Estimate
716M
Revenue Q2Q
18.68%
EPS Q2Q
34.05%
Number of Analysts
13

Next Earnings Revisions

Revenue (1 Month)
-0.02%
Revenue (3 Months)
2.35%
EPS (1 Month)
-0.45%
EPS (3 Months)
0.92%

Next Earnings Summary

MEDP is expected to report earnings on 7/20/2026. The consensus EPS estimate for the next earnings is 4.16 USD and the consensus revenue estimate is 716.00M USD.
The next earnings revenue estimate has been revised upward by 2.35% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
MEDP revenue by date.MEDP revenue by date.
1.886B
29.17%		2.109B
11.84%		2.53B
19.97%		2.864B
13.19%		3.086B
7.75%		3.38B
9.53%		3.788B
12.07%		3.946B
4.17%		4.238B
7.40%		4.621B
9.04%		4.866B
5.30%
EBITDA
YoY % growth
MEDP ebitda by date.MEDP ebitda by date.
363.153M
20.61%		476.121M
31.11%		563.059M
18.26%		630.23M
11.93%		690.54M
9.57%		765.57M
10.87%		835.96M
9.19%		909.5M
8.80%		974.24M
7.12%		1.077B
10.55%		1.097B
1.86%
EBIT
YoY % growth
MEDP ebit by date.MEDP ebit by date.
336.825M
20.86%		446.87M
32.67%		534.935M
19.71%		601.5M
12.44%		662.32M
10.11%		735M
10.97%		806.14M
9.68%		878.82M
9.02%		944.83M
7.51%		1.047B
10.81%		1.072B
2.39%
Operating Margin
MEDP operating margin by date.MEDP operating margin by date.
17.86%21.19%21.14%21.00%21.46%21.75%21.28%22.27%22.29%22.66%22.03%
EPS
YoY % growth
MEDP eps by date.MEDP eps by date.
8.88
21.31%		12.63
42.23%		15.30
21.14%		17.46
14.10%		19.36
10.88%		21.69
12.04%		23.81
9.78%		25.23
5.96%		27.43
8.73%		30.24
10.24%		30.00
-0.81%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27 Q1 / 28 Q2 / 28 Q3 / 28 Q4 / 28
EPS
Q2Q % growth		4.16
34.05%		4.52
17.14%		4.83
3.39%		4.50
5.16%		4.66
12.15%		5.02
11.04%		5.30
9.78%		4.56
1.41%		5.02
7.69%		5.59
11.43%		5.70
7.57%
Revenue
Q2Q % growth		716M
18.68%		719.19M
8.98%		722.29M
1.95%		739.96M
4.72%		762.78M
6.53%		785.35M
9.20%		804.25M
11.35%		830.69M
12.26%		860.32M
12.79%		888.98M
13.20%		911.12M
13.29%
EBITDA
Q2Q % growth		152.74M
8.88%		163.81M
0.62%		171.6M
-5.40%		157.37M
10.79%		168.03M
10.01%		178.88M
9.20%		185.73M
8.23%		167.08M
6.17%		183.96M
9.48%		205.58M
14.93%		210.02M
13.08%
EBIT
Q2Q % growth		145.31M
15.02%		156.36M
10.26%		164.51M
7.33%		148.85M
10.02%		160.86M
10.70%		172.44M
10.28%		179.78M
9.28%		160.65M
7.93%		178.19M
10.77%		198.24M
14.96%		202.42M
12.59%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MEDP Yearly Revenue VS EstimatesMEDP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
MEDP Yearly EPS VS EstimatesMEDP Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 10 20 30

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
12.34%
EPS Next 5 Year
10.52%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
9.69%
Revenue Next 5 Year
9.03%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
12.24%
EBIT Next 5 Year
10.93%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

MEDPACE HOLDINGS INC / MEDP Forecast FAQ

Can you provide the average price target for MEDPACE HOLDINGS INC stock?

20 analysts have analysed MEDP and the average price target is 503.37 USD. This implies a price increase of 22.61% is expected in the next year compared to the current price of 410.54.

Can you provide the upcoming earnings date for MEDPACE HOLDINGS INC?

MEDPACE HOLDINGS INC (MEDP) will report earnings on 2026-07-20, after the market close.

Can you provide the consensus estimates for MEDPACE HOLDINGS INC next earnings?

The consensus EPS estimate for the next earnings of MEDPACE HOLDINGS INC (MEDP) is 4.16 USD and the consensus revenue estimate is 716.00M USD.

What is the consensus rating for MEDP stock?

The consensus rating for MEDPACE HOLDINGS INC (MEDP) is 72 / 100 . This indicates that analysts generally have a positive outlook on the stock.